Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Arachidonate 5-lipoxygenase | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma japonicum | ko:K00461 arachidonate 5-lipoxygenase [EC1.13.11.34], putative | Get druggable targets OG5_127482 | All targets in OG5_127482 |
Schistosoma mansoni | lipoxygenase | Get druggable targets OG5_127482 | All targets in OG5_127482 |
Schistosoma mansoni | lipoxygenase | Get druggable targets OG5_127482 | All targets in OG5_127482 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | Get druggable targets OG5_127482 | All targets in OG5_127482 |
Schistosoma japonicum | IPR001024,Lipoxygenase, LH2;IPR013819,Lipoxygenase, C-terminal,domain-containing | Get druggable targets OG5_127482 | All targets in OG5_127482 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | Get druggable targets OG5_127482 | All targets in OG5_127482 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | glutathione synthetase | 0.0171 | 0.1236 | 0.1236 |
Echinococcus multilocularis | prenyl (decaprenyl) diphosphate synthase | 0.0171 | 0.1236 | 0.0534 |
Wolbachia endosymbiont of Brugia malayi | geranylgeranyl pyrophosphate synthase | 0.0171 | 0.1236 | 0.5 |
Loa Loa (eye worm) | polyprenyl synthetase | 0.0678 | 1 | 1 |
Toxoplasma gondii | polyprenyl synthetase superfamily protein | 0.0678 | 1 | 1 |
Echinococcus multilocularis | farnesyl pyrophosphate synthase | 0.0678 | 1 | 1 |
Mycobacterium tuberculosis | Probable geranylgeranyl pyrophosphate synthetase IdsA2 (ggppsase) (GGPP synthetase) (geranylgeranyl diphosphate synthase) | 0.0678 | 1 | 1 |
Trichomonas vaginalis | geranylgeranyl pyrophosphate synthase, putative | 0.0678 | 1 | 0.5 |
Schistosoma mansoni | memapsin-2 (A01 family) | 0.0542 | 0.7651 | 0.7651 |
Trypanosoma brucei | farnesyl pyrophosphate synthase | 0.0678 | 1 | 1 |
Trichomonas vaginalis | geranylgeranyl diphosphate synthase, putative | 0.0678 | 1 | 0.5 |
Schistosoma mansoni | trans-prenyltransferase | 0.0171 | 0.1236 | 0.1236 |
Trypanosoma cruzi | farnesyl pyrophosphate synthase | 0.0678 | 1 | 1 |
Plasmodium vivax | geranylgeranyl pyrophosphate synthase | 0.0678 | 1 | 1 |
Leishmania major | farnesyl pyrophosphate synthase | 0.0678 | 1 | 1 |
Schistosoma mansoni | farnesyl pyrophosphate synthase | 0.0678 | 1 | 1 |
Entamoeba histolytica | geranylgeranyl pyrophosphate synthase, putative | 0.0171 | 0.1236 | 0.5 |
Echinococcus multilocularis | geranylgeranyl pyrophosphate synthase | 0.0171 | 0.1236 | 0.0534 |
Echinococcus granulosus | decaprenyl diphosphate synthase subunit 1 | 0.0171 | 0.1236 | 0.0534 |
Schistosoma mansoni | lipoxygenase | 0.0142 | 0.0741 | 0.0741 |
Trichomonas vaginalis | geranylgeranyl pyrophosphate synthase, putative | 0.0678 | 1 | 0.5 |
Mycobacterium ulcerans | geranylgeranyl pyrophosphate synthase | 0.0678 | 1 | 1 |
Echinococcus multilocularis | decaprenyl diphosphate synthase subunit 1 | 0.0171 | 0.1236 | 0.0534 |
Wolbachia endosymbiont of Brugia malayi | geranylgeranyl pyrophosphate synthase | 0.0171 | 0.1236 | 0.5 |
Plasmodium falciparum | geranylgeranyl pyrophosphate synthase, putative | 0.0678 | 1 | 1 |
Echinococcus granulosus | prenyl decaprenyl diphosphate synthase | 0.0171 | 0.1236 | 0.0534 |
Mycobacterium ulcerans | geranylgeranyl pyrophosphate synthase | 0.0678 | 1 | 1 |
Echinococcus granulosus | geranylgeranyl pyrophosphate synthase | 0.0171 | 0.1236 | 0.0534 |
Chlamydia trachomatis | geranylgeranyl pyrophosphate synthase | 0.0171 | 0.1236 | 0.5 |
Entamoeba histolytica | bifunctional short chain isoprenyl diphosphate synthase, putative | 0.0171 | 0.1236 | 0.5 |
Mycobacterium leprae | PROBABLE POLYPRENYL-DIPHOSPHATE SYNTHASE GRCC1 (POLYPRENYL PYROPHOSPHATE SYNTHETASE) | 0.0171 | 0.1236 | 0.5 |
Entamoeba histolytica | geranylgeranyl pyrophosphate synthetase, putative | 0.0171 | 0.1236 | 0.5 |
Giardia lamblia | Farnesyl diphosphate synthase | 0.0678 | 1 | 0.5 |
Trypanosoma cruzi | farnesyl pyrophosphate synthase, putative | 0.0678 | 1 | 1 |
Echinococcus granulosus | farnesyl pyrophosphate synthase | 0.0678 | 1 | 1 |
Schistosoma mansoni | geranylgeranyl pyrophosphate synthase | 0.0171 | 0.1236 | 0.1236 |
Treponema pallidum | octaprenyl-diphosphate synthase | 0.0171 | 0.1236 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Control (functional) | = 66 % | Hypolipidemic activity in CF1 male mice at a dose of 20 mg/kg per day, serum cholesterol measured on the 16th day | ChEMBL. | 4067989 |
Control (functional) | = 66 % | Hypolipidemic activity in CF1 male mice at a dose of 20 mg/kg per day, serum triglyceride measured on the 16th day | ChEMBL. | 4067989 |
Control (functional) | = 66 % | Hypolipidemic activity in CF1 male mice at a dose of 20 mg/kg per day, serum cholesterol measured on the 16th day | ChEMBL. | 4067989 |
Control (functional) | = 66 % | Hypolipidemic activity in CF1 male mice at a dose of 20 mg/kg per day, serum triglyceride measured on the 16th day | ChEMBL. | 4067989 |
Control (functional) | = 72 % | Hypolipidemic activity in CF1 male mice at a dose of 20 mg/kg per day, serum cholesterol measured on the 9th day | ChEMBL. | 4067989 |
Control (functional) | = 72 % | Hypolipidemic activity in CF1 male mice at a dose of 20 mg/kg per day, serum cholesterol measured on the 9th day | ChEMBL. | 4067989 |
IC50 (binding) | = 3.2 uM | In vitro inhibition of 5-lipoxygenase activity in RBL-1 cells. | ChEMBL. | No reference |
IC50 (binding) | = 3.2 uM | In vitro inhibition of 5-lipoxygenase activity in RBL-1 cells. | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.